ArticleCureus2025
Opportunistic Cervical Cancer Screening During Antenatal Visits: A Small Step Toward Early Detection.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Approaches to Intraepithelial Cervical Neoplasia Management in Pregnancy: A Narrative Review.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Cervical cancer remains a significant public health concern in India. The objective of this study was to compare cytological abnormalities and HPV positivity rates between pregnant and non-pregnant women. Materials and methods This prospective observational study was performed at a tertiary care center in North India. A total of 120 women were included in the study, with 60 in each group. Group A included women who were pregnant, and Group B included non-pregnant women. Conventional Pap smear and co-testing (liquid-based cytology (LBC) and human papillomavirus deoxyribonucleic acid (HPV DNA)) were done on all the participants. The smears were interpreted according to the Bethesda system of classification. The results in the two groups were compared. Follow-up and management were done as per standard guidelines. Results Cervical smear was satisfactory in 112 (93.3%) and 116 (96.7%) of women who underwent conventional Pap smear and LBC, respectively. Among the premalignant lesions in Group A, atypical squamous cells of undetermined significance (ASC-US) were found in four (6.67%) of patients, and low-grade intraepithelial lesion (LSIL) was found in two (3.33%) of patients. In Group B, ASC-US was seen in five (8.33%), LSIL in three (5%), and high-grade squamous intraepithelial lesion (HSIL) in one (1.6%) case, respectively. The women in both groups who tested positive for HPV DNA were retested as per guidelines. Conclusions The prevalence of cytological abnormalities and HPV DNA positivity was corroborated well in both pregnant and non-pregnant women. Due to the increased number of antenatal visits and institutional deliveries, we would like to emphasize that screening for cervical cancer can be done by either HPV DNA or cytology in the antenatal period.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.